10/02/2017
https://congress.gov...
"PhRMA is opposed to any legislation that would require pharmaceutical manufacturers to provide basic transparency to the American people."
"My legislation, the Fair Drug Pricing Act, H.R. 2296, is a bipartisan, bicameral bill that will force the drug companies to be transparent."
"I welcome H.R. 2600 introduced by Representative Dean which takes the same approach for PFAS chemicals."
"I think it would be a very wise move to deal with a class of compounds that is persistent, bioaccumulative, and toxic and mobile."